Trial intelligence / Profile preview

ARTEM-TB Study

PACTR201302000483287Completed

Sponsor
Infectious Diseases Institute
Start
Jan 2013
Modality
Small Molecules
Countries
1
01

Overview

Trial of dihydroartemisinin + piperaquine, artesunate + amodiaquine and artesunate in malaria, sponsored by Infectious Diseases Institute. Started Jan 2013; status: completed.

02

Drugs

dihydroartemisinin + piperaquineartesunate + amodiaquineartesunate
03

Conditions

malaria

Beyond the preview

Go deeper on PACTR201302000483287.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201302000483287.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call